The difference with BLT compared with PAB is that the whole RNAi...

The difference with BLT compared with PAB is that the whole RNAi sector is red hot atm (unlike MAB's) and lots of US investors are looking for the next big thing; and the placement is into the US, further establishing our market over there. On the 28th of Feb it will become easier to trade BLT in the US, just 4 days away. I also think Aussie placements into biotech follow the same old tired pattern of dumb Aussie instos just making a quick buck, while the US biotech instos are more longer term investors.